The first nationwide study to assess the frequency of blood component bacterial contamination associated with transfusion reaction.

U.S. Public Health Service Guidelines for testing and counseling blood and plasma donors for HIV 1 antigen.

Recalls, withdrawals, safety issues of fractionated blood and plasma products from the FDA.

The safety implications of plasma pool sizes in the manufacture of fractionated blood products.